Eli Lilly weight management drug Zepbound landed its much anticipated FDA approval. The new Lilly product is in the same drug class as Novo Nordisk weight medication Wegovy, but it offers an additional mechanism of action and costs less.
FDA Approves Eli Lilly Weight Drug, Now Set to Compete Against Novo’s Wegovy
